Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for STRATA Skin Sciences (SSKN) over the last 11 years, with Q3 2025 value amounting to $4.5 million.

  • STRATA Skin Sciences' Shares Outstanding (Diluted Average) rose 1095.2% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 1095.2%. This contributed to the annual value of $3.8 million for FY2024, which is 902.71% up from last year.
  • Latest data reveals that STRATA Skin Sciences reported Shares Outstanding (Diluted Average) of $4.5 million as of Q3 2025, which was up 1095.2% from $4.2 million recorded in Q2 2025.
  • STRATA Skin Sciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $34.9 million during Q1 2023, with a 5-year trough of $3.5 million in Q2 2023.
  • For the 5-year period, STRATA Skin Sciences' Shares Outstanding (Diluted Average) averaged around $18.3 million, with its median value being $4.5 million (2025).
  • In the last 5 years, STRATA Skin Sciences' Shares Outstanding (Diluted Average) plummeted by 8995.46% in 2023 and then surged by 1897.12% in 2025.
  • STRATA Skin Sciences' Shares Outstanding (Diluted Average) (Quarter) stood at $34.1 million in 2021, then rose by 1.94% to $34.7 million in 2022, then plummeted by 89.94% to $3.5 million in 2023, then grew by 9.03% to $3.8 million in 2024, then increased by 17.71% to $4.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $4.5 million for Q3 2025, versus $4.2 million for Q2 2025 and $4.2 million for Q1 2025.